Form 4: Celcuity CSO Exercises Stock Options

Chief Science Officer Lance G. Laing exercised 1,000 stock options in Celcuity Inc. on June 2, 2026.

Summary

• Lance G. Laing, Chief Science Officer of Celcuity Inc., exercised 1,000 stock options.
• The exercise price for these options was $9.89 per share.
• Following the transaction, the reporting person holds 1,251,000 shares of common stock directly.
• The remaining balance of derivative securities (stock options) held by the reporting person is 20,250.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing standard executive equity management rather than a shift in company performance or sentiment.

Positives

• Insider demonstrates continued commitment to the company through the exercise of equity incentives.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine insider transaction filing.

Industry Context

StockSavvy.ai notes that routine option exercises by C-suite executives in the biotechnology sector are standard compensation-related activities and generally do not signal a change in corporate strategy or outlook.

Comparison to Industry Standards

• The transaction is consistent with standard executive compensation practices in the small-cap biotech industry.
• The exercise price and volume are immaterial relative to the total outstanding shares of the company.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine exercise of vested options.

Next Steps

• None.

Key Dates

Keywords

Celcuity, CELC, Insider Trading, Form 4, Stock Options, Biotech